IVZ

Invesco LTD · NYSE

$28.81USDCS band Mixed

↑ $0.28 (0.96%) Today

As of Oct 27, 1:05 PM ET · May be delayed

Sign up free to see this.

Daily prices
Mkt Cap
$12.7B
Volume
6.9M
52W High
$33.66
52W Low
$20.67
PE Ratio
—
Avg Vol
5M
As of 10/26/26
Div Yield
5.82%
Beta
1.72
As of 10/26/26

Analysts

All ›

Targets are shown as reported, adjusted only for stock splits, not as predictions. Not investment advice.

Sentiment

No sentiment yet

At least 5 tagged posts are needed.

How do you feel about IVZ?

Latest news

News ›

Zacks Investment Research

Here's Why Invesco (IVZ) is a Strong Growth Stock

Invesco Ltd. (IVZ) is highlighted as a potential growth investment opportunity with a #3 (Hold) Zacks Rank and a B VGM Score. The company forecasts 38.9% year-over-year earnings growth for the current fiscal year, with three analysts revising earnings estimates upward in the last 60 days. IVZ has a strong average earnings surprise of +12.5% and manages $2.47 trillion in assets under management across more than 120 countries.

Zacks Investment Research

Grab These 3 Top-Ranked Invesco Mutual Funds for Strong Growth

Zacks highlights three Invesco mutual funds with Strong Buy ratings: Invesco Discovery (OPOCX) with 23.3% three-year returns focusing on small-cap growth stocks, Invesco Energy Inv (FSTEX) with 15.7% three-year returns investing in energy sector securities, and Invesco Small Cap Growth (GTSYX) with 13.7% three-year returns tracking Russell 2000 Index companies.

Zacks Investment Research

Blue Owl Capital Inc. (OWL) Reports Next Week: What Awaits?

Blue Owl Capital (OWL) is expected to report flat earnings with modest 2.4% revenue growth for Q3 2026, but a negative Earnings ESP of -1.50% combined with a Zacks Rank #4 makes an earnings beat unlikely. Similarly, Invesco (IVZ) faces a -0.19% Earnings ESP despite expected 21.3% EPS growth, making it difficult to predict an earnings beat despite a Zacks Rank #3.

Headlines link to the publisher. Not investment advice.

Board · 0 threads

Open board ›

Cylvex posts are automated counts of published analyst actions, not opinions. Not investment advice.

Cylvex is a financial simulation and community platform designed for educational and informational purposes only. Market data may be delayed. Nothing on this platform constitutes investment advice, financial advice, trading advice, or any other sort of advice. You should not treat any of the platform's content as such. Cylvex does not recommend that any financial instrument should be bought, sold, or held by you. Do conduct your own due diligence and consult your financial advisor before making any investment decisions. By using Cylvex, you acknowledge that you are using the platform at your own risk.